Steve Young


Chief Scientific Officer, CluePoints


Quality Tolerance Limits: A Review of Industry Trends

March 02, 2023

Industry sees high increase in the use of QTLs.

Identifying Important Risk Indicators in Clinical Development

December 02, 2022

Study indentifies trends in most commonly used KRIs.

Ensuring Quality in Clinical Research with Centralized Statistical Monitoring, On-Site Monitoring, and Clinical Data Management

September 14, 2020

Organizations implementing RBM continue to struggle with a number of questions regarding the relative contributions to quality of on-site monitoring, centralized statistical monitoring, and clinical data management reviews—and what role each activity should play.

A Roadmap for Implementing Risk-Based Monitoring and Quality Management

April 08, 2019

Integrating a systemic risk management strategy for identifying clinical trial risks-and the importance of applying change management techniques throughout the preparation, planning, and execution stages.